Treatment of Recurrent Enterococcus Prostatitis

Introduction to Treatment

The American College of Cardiology is not relevant here, however, the recommended treatment for recurrent Enterococcus prostatitis is high-dose daptomycin 10-12 mg/kg/day IV combined with ampicillin 2g IV every 6 hours for 8 weeks, assuming the Enterococcus strain remains ampicillin-susceptible, with a strength of evidence based on clinical guidelines 1

Biofilm formation within prostatic tissue is a possible cause of recurrent enterococcal prostatitis, with a strength of evidence based on clinical studies 2
The development of resistance is a possible cause of recurrent enterococcal prostatitis, with a strength of evidence based on clinical studies 3

Obtaining susceptibility testing immediately to confirm ampicillin susceptibility and rule out high-level aminoglycoside resistance, vancomycin resistance, or daptomycin resistance is crucial, with a strength of evidence based on clinical guidelines 2
Obtaining baseline CPK level, complete blood count, and renal function before starting daptomycin is necessary, with a strength of evidence based on clinical guidelines 1
Arranging infectious disease consultation is a Class I recommendation for managing relapsed enterococcal infections, with a strength of evidence based on clinical guidelines 3, 4, 5, 1

If the Enterococcus strain is ampicillin-resistant or the patient cannot tolerate beta-lactams, linezolid 600 mg orally or IV every 12 hours for 6 weeks is the recommended alternative, with a success rate of 80-86% for chronic enterococcal prostatitis, and a strength of evidence based on clinical guidelines 1

Weekly CPK levels throughout therapy, and weekly renal function tests due to potential nephrotoxicity are necessary when using the daptomycin-ampicillin regimen, with a strength of evidence based on clinical guidelines 1
Weekly complete blood counts if treatment exceeds 2 weeks due to myelosuppression risk are necessary when using the linezolid regimen, with a strength of evidence based on clinical guidelines 1

Initial symptom improvement is expected within 5-7 days, with a more complete clinical response expected within 10-14 days, and microbiological documentation of cure expected within 2-4 weeks, with a strength of evidence based on clinical guidelines 1

If susceptibility testing reveals high-level aminoglycoside resistance, ampicillin 2g IV every 4 hours plus ceftriaxone 2g IV every 12 hours for 6 weeks is an effective alternative, with a strength of evidence based on clinical studies 5, 2

Never perform prostatic massage during acute symptoms or active infection, as it can precipitate bacteremia and potentially endocarditis, with a strength of evidence based on clinical guidelines 2

Post-treatment urine cultures at 1, 3, and 6 months are necessary to document sustained cure, with a strength of evidence based on clinical guidelines 2
Consideration of suppressive therapy is necessary if the patient relapses again after appropriate combination treatment, with a strength of evidence based on clinical guidelines 1